Form 4 · Filed May 9, 2026, 01:16 AM UTC
EW/Edwards Lifesciences Corp
Dahl Andrew M. — SVP, Corporate Controller
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 8, 2026 | F | other | 289 | $83 | $23,918 | 15,902 |
| May 7, 2026 | A | other | 3,985 | $0 | $0 | 13,171 |
| May 7, 2026 | A | other | 3,020 | $0 | $0 | 16,191 |
| May 7, 2026 | A | other | 6,745 | — | — | 6,745 |
Source: SEC EDGAR raw filing ↗ · Accession 0001225208-26-005044